Objective: To determine if differences exist between gynecologic cancer patients who participate in clinical trials and those who do not.
Study Design: Two hundred thirty-six subjects with gynecologic cancer diagnosed between 1997 and 2001 were identified. Multiple clinical and demographic factors, including clinical trial enrollment, postoperative treatment and related complications, were recorded.